Sandra Patterson - Dec 10, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
SVP, Controllership
Signature
/s/ Edward S. Son by Power of Attorney for Sandra C. Patterson
Stock symbol
GILD
Transactions as of
Dec 10, 2023
Transactions value $
-$17,542
Form type
4
Date filed
12/11/2023, 07:08 PM
Previous filing
Sep 11, 2023
Next filing
Dec 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +518 +1.72% 30.6K Dec 10, 2023 Direct F1
transaction GILD Common Stock Tax liability -$17.5K -222 -0.72% $79.02 30.4K Dec 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -518 -3.04% 16.5K Dec 10, 2023 Common Stock 518 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.